Collectively, the results of the in vivo experiments suggest that endothelial GSDMD-mediated systemic vascular injury and lethality are dependent on hepatocytic GSDMD-mediated HMGB1 release in endotoxemia. Here, HMGB1 is linked to serum lipopolysaccharide activity.